Ascension To Buy Out CHS’ Stake In Texas Hospital For $460M
CHS and Ascension unveiled the latest deal as hospital mergers and acquisitions are generally trending down amid market volatility.
Federal Funding Cuts Pose Challenges For Life Sciences Real Estate
According to Savills Research and Data Services’ Q1 U.S. Life Sciences Market Overview, proposed cuts to National Institutes of Health funding could significantly impact demand for life sciences real estate. A suggested 15% cap on indirect costs would limit support for facilities and administrative expenses, potentially forcing research institutions to downsize and startups to halt or slow operations.
Cautious Optimism On The Lending Side Of Healthcare Real Estate
After experiencing a challenging 2023, the healthcare real estate (HRE) lending sector saw some stabilization in 2024. As we look ahead to the remainder of 2025, what can we expect?
SUBSCRIBE
Receive newly posted industry news and information delivered right to your email inbox!
